North America Molecular Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents, Others), By Test Location, By Technology (PCR, ISH, INAAT, Sequencing), By Application, By Country, And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation and Scope
                        1.1.1. Segment Definitions
                            1.1.1.1. Product segment
                            1.1.1.2. Test Location segment
                            1.1.1.3. Technology segment
                            1.1.1.4. Application segment
                    1.2. Regional Scope
                    1.3. Estimates and Forecast Timeline
                    1.4. Objectives
                        1.4.1. Objective - 1
                        1.4.2. Objective - 2
                        1.4.3. Objective - 3
                    1.5. Research Methodology
                    1.6. Information Procurement
                        1.6.1. Purchased Database
                        1.6.2. GVR’s Internal Database
                        1.6.3. Secondary Sources
                        1.6.4. Primary research
                    1.7. Information or Data Analysis
                        1.7.1. Data Analysis Models
                    1.8. Market Formulation & Validation
                    1.9. Model Details
                        1.9.1. Commodity Flow Analysis
                    1.10. List of Secondary Sources
                    1.11. List of Abbreviations
Chapter 2. Executive Summary
                    2.1. Market Snapshot
                    2.2. Product and Test Location Snapshot
                    2.3. Technology and Application Snapshot
                    2.4. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent Market Outlook
                        3.1.2. Related/Ancillary Market Outlook
                    3.2. Market Dynamics
                        3.2.1. Market Driver Analysis
                            3.2.1.1. Increase in geriatric population
                            3.2.1.2. Introduction of technologically advanced products
                            3.2.1.3. Increase in demand for point-of-care testing
                            3.2.1.4. Growing prevalence of target diseases
                            3.2.1.5. Increasing external funding for R&D
                        3.2.2. Market Restraint Analysis
                            3.2.2.1. Presence of ambiguous regulatory framework
                            3.2.2.2. High prices of molecular diagnostics tests
                    3.3. Industry Analysis Tools
                        3.3.1. Porter’s Five Forces Analysis
                        3.3.2. PESTEL Analysis
                        3.3.3. COVID-19 Impact Analysis
Chapter 4. North America Molecular Diagnostics Market: Product Business Analysis
                    4.1. North America Molecular Diagnostics Market: Product Movement Analysis
                    4.2. Instruments
                        4.2.1. Instruments Market, 2018 - 2030 (USD Million)
                    4.3. Reagents
                        4.3.1. Reagents Market, 2018 - 2030 (USD Million)
                    4.4. Others
                        4.4.1. Others Market, 2018 - 2030 (USD Million)
Chapter 5. North America Molecular Diagnostics Market: Test Location Business Analysis
                    5.1. North America Molecular Diagnostics Market: Test Location Movement Analysis
                    5.2. Point-of-Care
                        5.2.1. Point-of-Care Market, 2018 - 2030 (USD Million)
                    5.3. Self-test or Over the Counter
                        5.3.1. Self-test or Over the Counter Market, 2018 - 2030 (USD Million)
                    5.4. Central Laboratories
                        5.4.1. Central Laboratories Market, 2018 - 2030 (USD Million)
Chapter 6. North America Molecular Diagnostics Market: Technology Business Analysis
                    6.1. North America Molecular Diagnostics Market: Technology Movement Analysis
                    6.2. PCR
                        6.2.1. PCR Market, 2018 - 2030 (USD Million)
                            6.2.1.1. PCR, by Type
                                6.2.1.1.1. PCR, by Type Market, 2018 - 2030 (USD Million)
                                    6.2.1.1.1.1. Multiplex PCR
                                        6.2.1.1.1.1.1. Multiplex PCR Market, 2018 - 2030 (USD Million)
                                    6.2.1.1.1.2. Other PCR
                                        6.2.1.1.1.2.1. Other PCR Market, 2018 - 2030 (USD Million)
                            6.2.1.2. PCR, by Procedure
                                6.2.1.2.1. PCR, by Procedure Market, 2018 - 2030 (USD Million)
                                    6.2.1.2.1.1. Nucleic Acid Extraction
                                        6.2.1.2.1.1.1. Nucleic Acid Extraction Market, 2018 - 2030 (USD Million)
                                    6.2.1.2.1.2. Others
                                        6.2.1.2.1.2.1. Others Market, 2018 - 2030 (USD Million)
                            6.2.1.3. PCR, by Product
                                6.2.1.3.1. PCR, by Product Market, 2018 - 2030 (USD Million)
                                    6.2.1.3.1.1. Instruments
                                        6.2.1.3.1.1.1. Instruments Market, 2018 - 2030 (USD Million)
                                    6.2.1.3.1.2. Reagents
                                        6.2.1.3.1.2.1. Reagents Market, 2018 - 2030 (USD Million)
                                    6.2.1.3.1.3. Others
                                        6.2.1.3.1.3.1. Others Market, 2018 - 2030 (USD Million)
                    6.3. In Situ Hybridization (ISH)
                        6.3.1. In Situ Hybridization (ISH) Market, 2018 - 2030 (USD Million)
                        6.3.2. Instruments
                            6.3.2.1. Instruments Market, 2018 - 2030 (USD Million)
                        6.3.3. Reagents
                            6.3.3.1. Reagents Market, 2018 - 2030 (USD Million)
                        6.3.4. Others Market, 2018 - 2030 (USD Million)
                            6.3.4.1. Others Market, 2018 - 2030 (USD Million)
                    6.4. Isothermal Nucleic Acid Amplification Technology (INAAT)
                        6.4.1. Isothermal Nucleic Acid Amplification Technology (INAAT) Market, 2018 - 2030 (USD Million)
                        6.4.2. Instruments
                            6.4.2.1. Instruments Market, 2018 - 2030 (USD Million)
                        6.4.3. Reagents
                            6.4.3.1. Reagents Market, 2018 - 2030 (USD Million)
                        6.4.4. Others Market, 2018 - 2030 (USD Million)
                            6.4.4.1. Others Market, 2018 - 2030 (USD Million)
                    6.5. Chips and Microarrays
                        6.5.1. Chips and Microarrays Market, 2018 - 2030 (USD Million)
                        6.5.2. Instruments
                            6.5.2.1. Instruments Market, 2018 - 2030 (USD Million)
                        6.5.3. Reagents
                            6.5.3.1. Reagents Market, 2018 - 2030 (USD Million)
                        6.5.4. Others Market, 2018 - 2030 (USD Million)
                            6.5.4.1. Others Market, 2018 - 2030 (USD Million)
                    6.6. Mass Spectroscopy
                        6.6.1. Mass Spectroscopy Market, 2018 - 2030 (USD Million)
                        6.6.2. Instruments
                            6.6.2.1. Instruments Market, 2018 - 2030 (USD Million)
                        6.6.3. Reagents
                            6.6.3.1. Reagents Market, 2018 - 2030 (USD Million)
                        6.6.4. Others Market, 2018 - 2030 (USD Million)
                            6.6.4.1. Others Market, 2018 - 2030 (USD Million)
                    6.7. Sequencing
                        6.7.1. Sequencing Market, 2018 - 2030 (USD Million)
                        6.7.2. Instruments
                            6.7.2.1. Instruments Market, 2018 - 2030 (USD Million)
                        6.7.3. Reagents
                            6.7.3.1. Reagents Market, 2018 - 2030 (USD Million)
                        6.7.4. Others Market, 2018 - 2030 (USD Million)
                            6.7.4.1. Others Market, 2018 - 2030 (USD Million)
                    6.8. Transcription Mediated Amplification (TMA)
                        6.8.1. Transcription Mediated Amplification (TMA) Market, 2018 - 2030 (USD Million)
                        6.8.2. Instruments
                            6.8.2.1. Instruments Market, 2018 - 2030 (USD Million)
                        6.8.3. Reagents
                            6.8.3.1. Reagents Market, 2018 - 2030 (USD Million)
                        6.8.4. Others Market, 2018 - 2030 (USD Million)
                            6.8.4.1. Others Market, 2018 - 2030 (USD Million)
                    6.9. Others
                        6.9.1. Others Market, 2018 - 2030 (USD Million)
                        6.9.2. Instruments
                            6.9.2.1. Instruments Market, 2018 - 2030 (USD Million)
                        6.9.3. Reagents
                            6.9.3.1. Reagents Market, 2018 - 2030 (USD Million)
                        6.9.4. Others Market, 2018 - 2030 (USD Million)
                            6.9.4.1. Others Market, 2018 - 2030 (USD Million)
Chapter 7. North America Molecular Diagnostics Market: Application Business Analysis
                    7.1. North America Molecular Diagnostics Market: Application Movement Analysis
                    7.2. Oncology
                        7.2.1. Oncology Market, 2018 - 2030 (USD Million)
                        7.2.2. Breast Cancer
                            7.2.2.1. Breast Cancer Market, 2018 - 2030 (USD Million)
                        7.2.3. Prostate Cancer
                            7.2.3.1. Prostate Cancer Market, 2018 - 2030 (USD Million)
                        7.2.4. Colorectal Cancer Market, 2018 - 2030 (USD Million)
                            7.2.4.1. Colorectal Cancer Market, 2018 - 2030 (USD Million)
                        7.2.5. Cervical Cancer
                            7.2.5.1. Cervical Cancer Market, 2018 - 2030 (USD Million)
                        7.2.6. Kidney Cancer
                            7.2.6.1. Kidney Cancer Market, 2018 - 2030 (USD Million)
                        7.2.7. Liver Cancer Market, 2018 - 2030 (USD Million)
                            7.2.7.1. Liver Cancer Market, 2018 - 2030 (USD Million)
                        7.2.8. Blood Cancer
                            7.2.8.1. Blood Cancer Market, 2018 - 2030 (USD Million)
                        7.2.9. Lung Cancer
                            7.2.9.1. Lung Cancer Market, 2018 - 2030 (USD Million)
                        7.2.10. Other Cancer Market, 2018 - 2030 (USD Million)
                            7.2.10.1. Other Cancer Market, 2018 - 2030 (USD Million)
                    7.3. Pharmacogenomics
                        7.3.1. Pharmacogenomics Market, 2018 - 2030 (USD Million)
                    7.4. Infectious Diseases
                        7.4.1. Infectious Diseases Market, 2018 - 2030 (USD Million)
                        7.4.2. Methicillin-resistant Staphylococcus Aureus (MRSA)
                            7.4.2.1. Methicillin-resistant Staphylococcus Aureus (MRSA) Market, 2018 - 2030 (USD Million)
                        7.4.3. Clostridium Difficile
                            7.4.3.1. Clostridium Difficile Market, 2018 - 2030 (USD Million)
                        7.4.4. Vancomycin-resistant Enterococci (VRE)
                            7.4.4.1. Vancomycin-resistant Enterococci (VRE) Market, 2018 - 2030 (USD Million) Instruments
                        7.4.5. Carbapenem-resistant Bacteria
                            7.4.5.1. Carbapenem-resistant Bacteria Market, 2018 - 2030 (USD Million)
                        7.4.6. Flu
                            7.4.6.1. Flu Market, 2018 - 2030 (USD Million)
                        7.4.7. Candida Market, 2018 - 2030 (USD Million)
                            7.4.7.1. Candida Market, 2018 - 2030 (USD Million)
                        7.4.8. Tuberculosis and Drug-resistant TBA
                            7.4.8.1. Tuberculosis and Drug-resistant TBA Market, 2018 - 2030 (USD Million)
                        7.4.9. Meningitis
                            7.4.9.1. Meningitis Market, 2018 - 2030 (USD Million)
                        7.4.10. Gastrointestinal Panel Testing
                            7.4.10.1. Gastrointestinal Panel Testing Market, 2018 - 2030 (USD Million)
                        7.4.11. Chlamydia
                            7.4.11.1. Chlamydia Market, 2018 - 2030 (USD Million)
                        7.4.12. Gonorrhea
                            7.4.12.1. Gonorrhea Market, 2018 - 2030 (USD Million)
                        7.4.13. HIV
                            7.4.13.1. HIV Market, 2018 - 2030 (USD Million)
                        7.4.14. Hepatitis C
                            7.4.14.1. Hepatitis C Market, 2018 - 2030 (USD Million)
                        7.4.15. Hepatitis B
                            7.4.15.1. Hepatitis B Market, 2018 - 2030 (USD Million)
                        7.4.16. Others Infectious Diseases
                            7.4.16.1. Other Infectious Diseases Market, 2018 - 2030 (USD Million)
                    7.5. Genetic Testing
                        7.5.1. Genetic Testing Market, 2018 - 2030 (USD Million)
                        7.5.2. Newborn Screening
                            7.5.2.1. Newborn Screening Market, 2018 - 2030 (USD Million)
                        7.5.3. Predictive and Presymptomatic Testing
                            7.5.3.1. Predictive and Presymptomatic Market, 2018 - 2030 (USD Million)
                        7.5.4. Other Genetic Testing Market, 2018 - 2030 (USD Million) Instruments
                            7.5.4.1. Other Genetic Testing Market, 2018 - 2030 (USD Million)
                    7.6. Neurological Disease
                        7.6.1. Neurological Disease Market, 2018 - 2030 (USD Million)
                    7.7. Cardiovascular Disease
                        7.7.1. Cardiovascular Disease Market, 2018 - 2030 (USD Million)
                    7.8. Microbiology
                        7.8.1. Microbiology Market, 2018 - 2030 (USD Million)
                    7.9. Others
                        7.9.1. Others Market, 2018 - 2030 (USD Million)
Chapter 8. North America Molecular Diagnostics Market: Country Business Analysis
                    8.1. North America
                        8.1.1. North America Molecular Diagnostics Market, 2018 - 2030 (USD Million)
                        8.1.2. U.S.
                            8.1.2.1. Key Country Dynamics
                            8.1.2.2. Target Disease Prevalence
                            8.1.2.3. Competitive Scenario
                            8.1.2.4. Regulatory Framework
                            8.1.2.5. U.S. Molecular Diagnostics Market, 2018 - 2030 (USD Million)
                        8.1.3. Canada
                            8.1.3.1. Key Country Dynamics
                            8.1.3.2. Target Disease Prevalence
                            8.1.3.3. Competitive Scenario
                            8.1.3.4. Regulatory Framework
                            8.1.3.5. Canada Molecular Diagnostics Market, 2018 - 2030 (USD Million)
Chapter 9. North America Molecular Diagnostics Market: Competitive Landscape
                     8.1. Participant Categorization
                        9.1.1. BD
                            9.1.1.1. Overview
                            9.1.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            9.1.1.3. Product Benchmarking
                            9.1.1.4. Strategic Initiatives
                        9.1.2. Bio-Rad Laboratories, Inc.
                            9.1.2.1. Overview
                            9.1.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            9.1.2.3. Product Benchmarking
                            9.1.2.4. Strategic Initiatives
                        9.1.3. Abbott
                            9.1.3.1. Overview
                            9.1.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            9.1.3.3. Product Benchmarking
                            9.1.3.4. Strategic Initiatives
                        9.1.4. Agilent Technologies, Inc.
                            9.1.4.1. Overview
                            9.1.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            9.1.4.3. Product Benchmarking
                            9.1.4.4. Strategic Initiatives
                        9.1.5. Danaher
                            9.1.5.1. Overview
                            9.1.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            9.1.5.3. Product Benchmarking
                            9.1.5.4. Strategic Initiatives
                        9.1.6. Hologic Inc. (Gen Probe)
                            9.1.6.1. Overview
                            9.1.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            9.1.6.3. Product Benchmarking
                            9.1.6.4. Strategic Initiatives
                        9.1.7. Illumina, Inc.
                            9.1.7.1. Overview
                            9.1.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            9.1.7.3. Product Benchmarking
                            9.1.7.4. Strategic Initiatives
                        9.1.8. Johnson & Johnson Services, Inc.
                            9.1.8.1. Overview
                            9.1.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            9.1.8.3. Product Benchmarking
                            9.1.8.4. Strategic Initiatives
                        9.1.9. Thermo Fisher Scientific Inc.
                            9.1.9.1. Overview
                            9.1.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            9.1.9.3. Product Benchmarking
                            9.1.9.4. Strategic Initiatives
                        9.1.10. F. Hoffmann-La Roche, Ltd.
                            9.1.10.1. Overview
                            9.1.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                            9.1.10.3. Product Benchmarking
                            9.1.10.4. Strategic Initiatives
                    9.2. Participant’s Overview
                    9.3. Financial Performance
                    9.4. Product Benchmarking
                    9.5. Company Market Share Analysis, 2023
                    9.6. Strategy Mapping
                        9.6.1. Expansion
                        9.6.2. Acquisition
                        9.6.3. Product/Service Launch
                        9.6.4. Others
Chapter 10. Analyst View

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 North America Molecular Diagnostics Market, By Country, 2018 - 2030 (USD Million)
Table 4 North America Molecular Diagnostics Market, By Product, 2018 - 2030 (USD Million)
Table 5 North America Molecular Diagnostics Market, By Test Location, 2018 - 2030 (USD Million)
Table 6 North America Molecular Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
Table 7 North America Molecular Diagnostics market, by Application, 2018 - 2030 (USD Million)
Table 8 U.S. Molecular Diagnostics market, by Product, 2018 - 2030 (USD Million)
Table 9 U.S. Molecular Diagnostics market, by Test Location, 2018 - 2030 (USD Million)
Table 10 U.S. Molecular Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
Table 11 U.S. Molecular Diagnostics market, by Application, 2018 - 2030 (USD Million)
Table 12 Canada Molecular Diagnostics market, by Product, 2018 - 2030 (USD Million)
Table 13 Canada Molecular Diagnostics market, by Test Location, 2018 - 2030 (USD Million)
Table 14 Canada Molecular Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
Table 15 Canada Molecular Diagnostics market, by Application, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 Market formulation & validation
Fig. 7 North America molecular diagnostics market segmentation
Fig. 8 Market snapshot, 2023
Fig. 9 Market Trends & Outlook
Fig. 10 Market driver relevance analysis (current & future impact)
Fig. 11 Market restraint relevance analysis (current & future impact)
Fig. 12 Market challenge relevance analysis (current & future impact)
Fig. 13 SWOT analysis
Fig. 14 Porter’s five forces analysis
Fig. 15 North America molecular diagnostics market: Product movement analysis
Fig. 16 Instruments market, 2018 - 2030 (USD Million)
Fig. 17 Reagents market, 2018 - 2030 (USD Million)
Fig. 18 Others market, 2018 - 2030 (USD Million)
Fig. 19 North America molecular diagnostics market: Test location movement analysis
Fig. 20 Point of care market, 2018 - 2030 (USD Million)
Fig. 21 Self-test or OTC market, 2018 - 2030 (USD Million)
Fig. 22 Central laboratories market, 2018 - 2030 (USD Million)
Fig. 23 North America molecular diagnostics market: Technology movement analysis
Fig. 24 PCR market, 2018 - 2030 (USD Million)
Fig. 25 Nucleic Acid Extraction PCR market, 2018 - 2030 (USD Million)
Fig. 26 Others PCR market, 2018 - 2030 (USD Million)
Fig. 27 Multiplex PCR market, 2018 - 2030 (USD Million)
Fig. 28 Other PCR market, 2018 - 2030 (USD Million)
Fig. 29 In Situ Hybridization market, 2018 - 2030 (USD Million)
Fig. 30 Isothermal Nucleic Acid Amplification Technology (INAAT) market, 2018 - 2030 (USD Million)
Fig. 31 Chips and microarrays market, 2018 - 2030 (USD Million)
Fig. 32 Mass spectrometry market, 2018 - 2030 (USD Million)
Fig. 33 Sequencing market, 2018 - 2030 (USD Million)
Fig. 34 Transcription mediated amplification market, 2018 - 2030 (USD Million)
Fig. 35 Others market, 2018 - 2030 (USD Million)
Fig. 36 North America molecular diagnostics market: Application movement analysis
Fig. 37 Oncology market, 2018 - 2030 (USD Million)
Fig. 38 Breast cancer market, 2018 - 2030 (USD Million)
Fig. 39 Prostate cancer market, 2018 - 2030 (USD Million)
Fig. 40 Colorectal cancer market, 2018 - 2030 (USD Million)
Fig. 41 Cervical cancer market, 2018 - 2030 (USD Million)
Fig. 42 Kidney cancer market, 2018 - 2030 (USD Million)
Fig. 43 Liver cancer market, 2018 - 2030 (USD Million)
Fig. 44 Blood cancer market, 2018 - 2030 (USD Million)
Fig. 45 Lung cancer market, 2018 - 2030 (USD Million)
Fig. 46 Other cancer market, 2018 - 2030 (USD Million)
Fig. 47 Pharmacogenomics market, 2018 - 2030 (USD Million)
Fig. 48 Infectious disease market, 2018 - 2030 (USD Million)
Fig. 49 MRSA market, 2018 - 2030 (USD Million)
Fig. 50 Clostridium difficile market, 2018 - 2030 (USD Million)
Fig. 51 Vancomycin-resistant enterococci market, 2018 - 2030 (USD Million)
Fig. 52 Carbapenem-resistant bacteria testing market, 2018 - 2030 (USD Million)
Fig. 53 Flu market, 2018 - 2030 (USD Million)
Fig. 54 Respiratory syncytial virus (RSV) market, 2018 - 2030 (USD Million)
Fig. 55 Candida market, 2018 - 2030 (USD Million)
Fig. 56 Tuberculosis and drug-resistant TB market, 2018 - 2030 (USD Million)
Fig. 57 Meningitis market, 2018 - 2030 (USD Million)
Fig. 58 Gastro-intestinal panel testing market, 2018 - 2030 (USD Million)
Fig. 59 Chlamydia market, 2018 - 2030 (USD Million)
Fig. 60 Gonorrhea market, 2018 - 2030 (USD Million)
Fig. 61 HIV market, 2018 - 2030 (USD Million)
Fig. 62 Hepatitis C market, 2018 - 2030 (USD Million)
Fig. 63 Hepatitis B market, 2018 - 2030 (USD Million)
Fig. 64 Other infectious diseases market, 2018 - 2030 (USD Million)
Fig. 65 Genetic testing market, 2018 - 2030 (USD Million)
Fig. 66 Newborn screening market, 2018 - 2030 (USD Million)
Fig. 67 Predictive and presymptomatic testing market, 2018 - 2030 (USD Million)
Fig. 68 Others market, 2018 - 2030 (USD Million)
Fig. 69 Neurological disease market, 2018 - 2030 (USD Million)
Fig. 70 Cardiovascular disease market, 2018 - 2030 (USD Million)
Fig. 71 Microbiology market, 2018 - 2030 (USD Million)
Fig. 72 Others market, 2018 - 2030 (USD Million)
Fig. 73 Regional marketplace: key takeaways
Fig. 74 Regional outlook, 2023 & 2030
Fig. 75 North America molecular diagnostics market: Country movement analysis.
Fig. 76 North America molecular diagnostics market, 2018 - 2030 (USD Million)
Fig. 77 U.S. key country dynamics
Fig. 78 U.S. molecular diagnostics market, 2018 - 2030 (USD Million)
Fig. 79 Canada key country dynamics
Fig. 80 Canada molecular diagnostics market, 2018 - 2030 (USD Million)